Skip to content

Price / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
4.4×-0.8×
Danaher logo
DanaherDHR
5.4×-0.7×
Repligen logo
RepligenRGEN
13.2×-0.1×
ADMA Biologics logo
ADMA BiologicsADMA
4.2×-6.1×
Revvity logo
RevvityRVTY
3.4×-1.2×
TEC
Bio-TechneTECH
6.8×-0.9×

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+186%
Enterprise value$954.59M+182%

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s price / sales?
Maravai LifeSciences Holdings, Inc. (MRVI) reported price / sales of 2× in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s price / sales changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s price / sales increased by 54.2% year-over-year, from 1.3× to 2×.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s price / sales?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s price / sales has grown at a -32.5% compound annual growth rate (CAGR), from 18.2× to 2.5×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.